Author

A. Bourdin

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP.

RATIONALE The efficacy of biologics remains debatable in current or ex- smokers with severe asthma. OBJECTIVES This study aimed to evaluate responses to biologics by smoking exposure and to assess variations in management practice across Europe. METHODS This was a retrospective real-world study of adults with sever...

M. Caminati, J. Charriot, A. Bansal et al. · American Journal of Respirat... · 1 citation

Open access Sep 2026

Dupilumab efficacy and safety in patients with allergic bronchopulmonary aspergillosis.

BACKGROUND Allergic bronchopulmonary aspergillosis (ABPA) is a complex allergic hypersensitivity reaction to Aspergillus species that can complicate and worsen concomitant asthma and is associated with an intense type 2 immune response in lower airways; there are no approved targeted therapies. OBJECTIVE To investiga...

A. Bourdin, J. Corren, A. Shah et al. · Journal of Allergy and Clini... · 0 citations

Sep 2026

Efficacy and Tolerance of a Combination of Targeted Therapies Indicated for Asthma and Chronic Inflammatory Rheumatism.

OBJECTIVE The use of combined targeted therapies is increasing in clinical practice, both within and across diseases. However, data on dual targeted therapy for patients with both chronic inflammatory rheumatism (CIR) and severe allergic asthma remain limited, especially regarding treatment outcomes and safety, includi...

L. Etronnier, Cédric Lukas, Baptiste Gérard et al. · Joint Bone Spine · 0 citations